NOXAFIL

• drugNOXAFIL POWDERMIX KIT242 co-mentions · 62 sources
• tagApproval240 co-mentions · 61 sources
• drugPOSACONAZOLE122 co-mentions · 62 sources
• drugposaconazole DR122 co-mentions · 62 sources
• tagSmall Molecule94 co-mentions · 48 sources
• company$OGNOrganon & Co.2 co-mentions · 1 sources
• companyMerck Sharp & Dohme LLC2 co-mentions · 1 sources
• tagRecall2 co-mentions · 1 sources

Trials studying NOXAFIL

• phase2Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpressionrecruitingn=84
• phase2A Study of BGB-11417 in Participants With Myeloid Malignanciesrecruitingn=260
• phase3Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantationcompletedn=602
• phase2Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)recruitingn=40
• phase4Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patientscompletedn=88
• phase4Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplantsrecruitingn=100
• —Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patientscompletedn=249
• phase2Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)completedn=31